USC researcher reveals how to better master stem cells’ fate

By Cristy Lytal

Qi-Long Ying and a team of researchers have discovered new ways to encourage human embryonic stem cells like these to self-renew. (Photo/Courtesy Qi-Long Ying) Qi-Long Ying and a team of researchers have discovered new ways to encourage human embryonic stem cells like these to self-renew.
(Photo/Courtesy Qi-Long Ying)

USC scientist Qi-Long Ying, PhD, MSc, and a team of researchers have long been searching for biotech’s version of the fountain of youth — ways to encourage embryonic stem cells (ESCs) and epiblast stem cells (EpiSCs) to endlessly self-renew, or divide to produce more stem cells.

In a pair of studies published in Nature Communications in September and a study in The EMBO Journal in August, Ying and his team revealed some of the ways that ESCs and EpiSCs retain their pluripotency, or ability to differentiate into virtually any kind of cell. Read More »

October 18th, 2013|Announcements|

Research team discovers protein’s ability to help and hinder cancer

By Cristy Lytal

Can the same gene prevent and promote cancer? When it comes to liver cancer, the gene that codes for P53, a protein found in humans and many other animals, can indeed do both.

In a pair of articles published in Oncogene and the Journal of Hepatology, Qi-Long Ying, PhD, associate professor of cell and neurobiology at the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, and a team of researchers revealed that P53 can both help and harm a liver exposed to carcinogenic chemicals. Read More »

October 18th, 2013|Announcements|

Pfizer’s J. Jean Cui explains modern drug discovery to Keck School students

By Marie Rippen

Only five percent of potential cancer drugs make it from phase I clinical trail to FDA approval, but J. Jean Cui, PhD, associate research fellow at Pfizer, beat the odds.

 J. Jean Cui of Pfizer shared her perspective on drug discovery with Keck School students as part of the Careers in Science seminar series.  (Photo/Cristy Lytal)
J. Jean Cui of Pfizer shared her perspective on drug discovery with Keck School students as part of the Careers in Science seminar series.
(Photo/Cristy Lytal)

Cui visited the Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research on Sept. 13 to share her perspective on drug discovery with students as part of the Careers in Science seminar series, presented by the center in conjunction with the USC School of Pharmacy and the USC Center for Excellence in Research. Read More »

October 17th, 2013|Announcements|

Excellent results from Keck Medicine laboratories

Laboratory members often go far beyond promoting discovery. They promote a stronger Keck Medicine community by raising funds and sharing award-winning images. Read More »

September 27th, 2013|Announcements|

USC teams with CIRM to celebrate Stem Cell Awareness Day

By Cristy Lytal

For the millions of people around the world who suffer from incurable diseases and injuries, Stem Cell Awareness Day is a time for hope.

In honor of the occasion, USC Stem Cell is joining institutions and educators from around the world in hosting a series of public events to raise awareness and celebrate this promising field of medicine in partnership with the California Institute for Regenerative Medicine (CIRM). Read More »

September 27th, 2013|Announcements|